Downloads

Download data is not yet available.

Abstract

Immune thrombocytopenia is characterized by reduced platelet count. This condition occurs in both adults and children. The most common form of thrombocytopenia is primary ITP and autoantibodies are involved in its development. In this study, our patient was a pregnant woman with ITP who showed refractory to prednisolone and splenectomy as first and second line treatment, respectively, but the response to treatment with Romiplostim and platelet count was favorable, and delivery was reported without fetal complications.



Author's Affiliation
Article Details

Issue: Vol 5 No 8 (2018)
Page No.: 2565-2571
Published: Aug 23, 2018
Section: Case report
DOI: https://doi.org/10.15419/bmrat.v5i8.465

 Copyright Info

Creative Commons License

Copyright: The Authors. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 How to Cite
Payandeh, M., Karami, A., Karami, N., & Masgareh, J. B. (2018). Romiplostim: Successful treatment of a pregnant woman with refractory immune thrombocytopenia. Biomedical Research and Therapy, 5(8), 2565-2571. https://doi.org/https://doi.org/10.15419/bmrat.v5i8.465

 Cited by

Article level Metrics by Paperbuzz/Impactstory
Article level Metrics by Altmetrics

 Article Statistics
HTML = 112 times
Download PDF   = 36 times
Total   = 36 times